FK506 was developed by Fujisawa Pharmaceutical of Osaka, Japan. It is commercially available in research quantities from Alexis Biochemicals. See http://www.alexis-corp.com/datasheets/380008ds.HTM It may also be available from other sources under FK506 or tacrolimus. Dick Haugland Molecular Probes, Inc.